Item 7.01 Regulation FD Disclosure.
Waters Corporation (the "Company") is furnishing as Exhibit 99.1 to this Current
Report on Form 8-K a presentation (the "Presentation") that it will present to
certain investors and market professionals at an "Investor Day" taking place at
the New York Stock Exchange on May 19, 2022 at 10AM EST. A live telecast will be
broadcast and may be accessed from the Company's website at
https://ir.waters.com. The Presentation provides for high-level commentary on
the historical performance of the Company's business and strategic initiatives
of the Company, as well as industry and company outlook in the near and midterm.
Readers are urged to review the presentation.
The Presentation contains forward-looking statements regarding future results
and events. For this purpose, any statements that are not statements of
historical fact may be deemed forward-looking statements. Words such as "may,"
"will," "expect," "plan," "anticipate," "estimate," "intend", "project" and
similar expressions (as well as other words or expressions referencing future
events, conditions or circumstances) are intended to identify forward-looking
statements. Forward-looking statements are based on current expectations and
assumptions and currently available data and are neither predictions nor
guarantees of future events or performance. You should not place undue reliance
on forward-looking statements, which speak only as of the date hereof and should
not be relied upon as representing the Company's estimates or views as of any
date subsequent to the date of this presentation. We do not undertake to update
or revise any forward-looking statements after they are made, whether as a
result of new information, future events, or otherwise, except as required by
applicable law. Please also note that the guidance provided in the Presentation
with respect to 2022, which was first publicly disclosed on May 3, 2022, is
included for reference purposes, only, and has not been updated or reaffirmed as
of this or any other date. The Company's actual future results may differ
significantly from the results discussed in the forward-looking statements
within this presentation for a variety of reasons, including and without
limitation, risks related to the effects of the ongoing COVID-19 pandemic on our
business, financial condition, results of operations and prospects, including:
portions of our global workforce being unable to work fully and/or effectively
due to working remotely, illness, quarantines, government actions, facility
closures or other reasons related to the pandemic, increased risks of
cyber-attacks resulting from our temporary remote working model, disruptions in
our manufacturing capabilities or to our supply chain, volatility and
uncertainty in global capital markets limiting our ability to access capital,
customers being unable to make timely payments for purchases and volatility in
demand for our products; foreign exchange rate fluctuations potentially
affecting translation of the Company's future non-U.S. operating results;
fluctuations in expenditures by the Company's customers, in particular large
pharmaceutical companies; environmental and logistical obstacles affecting the
distribution of products and risks associated with lawsuits and other legal
actions, particularly involving claims for infringement of patents and other
intellectual property rights. Such factors and others are discussed more fully
in the sections entitled "Forward-Looking Statements" and "Risk Factors" of the
Company's annual report on Form 10-K for the year ended December 31, 2021 as
filed with the Securities and Exchange Commission on February 24, 2022, as
updated by the Company's subsequent filings with the SEC including the Company's
Quarterly Reports on Form 10-Q.
The information contained under Item 7.01 in this Current Report on Form 8-K
(including Exhibit 99.1) is being furnished and shall not be deemed "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), or otherwise subject to the liabilities under that section, and
shall not be deemed incorporated by reference into any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly provided by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Number Description of Exhibits
99.1 Investor Presentation dated May 19, 2022.
104 The cover page from this Current Report on Form 8-K, formatted in
Inline XBRL.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
WATERS CORPORATION 
